Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cardiovascular genomics.

Jun Yoshioka1, Richard T Lee

  • 1Cardiovascular Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, 65 Landsdowne Street #279, Cambridge, MA 02139, USA.

Cardiovascular Pathology : the Official Journal of the Society for Cardiovascular Pathology
|September 26, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Therapeutic Role of Exercise in Diabetic Cardiomyopathy: Underlying Mechanisms and Interactions with Antidiabetic Medications.

Journal of cardiovascular pharmacology·2026
Same author

YBX1 as a Developmental Regulator of Ventricular Morphogenesis and a Potential Target in Cardiac Pathology.

American journal of physiology. Heart and circulatory physiology·2026
Same author

In situ graphene-seq: spatial transcriptomics and chronic electrophysiological characterization of tissue microenvironments.

Nature communications·2026
Same author

Spatial imprints of emergent cardiomyocyte states in the pressure-overloaded heart.

bioRxiv : the preprint server for biology·2026
Same author

Mutations in the Txnip PPXY motifs protect against myocardial infarction despite enhanced protein stability.

American journal of physiology. Heart and circulatory physiology·2026
Same author

NR4A2-driven metabolic reprogramming in the heart: from adaptive response to maladaptive remodeling.

Physiological genomics·2026
Same journal

Green Heart: Methylene Blue administration in a hemodynamically unstable infant following cardiac arrest due to parental co-sleeping.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

Adventitial Melanocytosis ("Blue nevus") of the Aorta.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

Lipomatous Hamartoma of the Semilunar Valve Exhibits Molecular Genetic Characteristics of Lipoma.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

Proteomic profiling of whole tissue sections in cardiac ATTR amyloidosis reveals increased extracellular matrix remodeling.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

A large-scale plasma proteomic study reveals the preclinical evolution and potential biomarkers for coronary atherosclerosis.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
Same journal

Burden of cardiovascular disease in victims of fatal intoxication: An autopsy study.

Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology·2026
See all related articles

Genomic and proteomic technologies are transforming cardiovascular science by identifying disease-causing genes and biomarkers. These advancements offer new diagnostic tools and therapeutic strategies for inherited and common heart conditions.

Area of Science:

  • Cardiovascular Science
  • Genomics
  • Proteomics

Background:

  • The rapid growth of genomic data is revolutionizing cardiovascular research.
  • Genomic maps facilitate the identification of genes responsible for monogenic inherited cardiovascular diseases.
  • Gene expression analysis in cardiovascular diseases is uncovering candidate genes and biomarkers for multifactorial conditions.

Purpose of the Study:

  • To highlight the impact of genomic and proteomic advancements on cardiovascular science.
  • To discuss the role of genomic information in identifying disease-causing genes and biomarkers.
  • To explore the potential of new technologies in cardiovascular disease diagnosis and therapy.

Main Methods:

  • Analysis of genomic information and gene expression variations.

Related Experiment Videos

  • Utilizing advanced genomic mapping techniques.
  • Leveraging emerging proteomic technologies.

    • Main Results:

    • Identification of genes causing monogenic inherited cardiovascular diseases.
    • Discovery of novel candidate genes and biomarkers for common cardiovascular diseases through gene expression analysis.
    • Generation of substantial datasets from genomic studies.

    Conclusions:

    • Genomic and proteomic technologies are essential tools for advancing cardiovascular science.
    • These technologies are crucial for diagnosing cardiovascular diseases and developing new therapeutic approaches.
    • Continued technological innovation promises further breakthroughs in cardiovascular medicine.